Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
138
Publications avec texte intégral
Open Access
53 %
Mots clés
Cardiac muscle
RNA interference
CTG repeat contractions
DMPK
Autophagy
Hypoxia
Centronuclear myopathy
Motoneuron
Gene therapy
Quantitative microdialysis
Muscle
Intermediate filament
Alternative splicing
Myotonic dystrophy type 1
Brain
Dilated cardiomyopathy
CONGENITAL MYATHENIC SYNDROME
Transcriptomics
Glutamate
Neuron
Acetylcholinesterase deficiency
In vivo
Heart failure
Long read sequencing
Gene Therapy
Dystrophin
Male
Central nervous system
DM1
Exercice
BIOLOGIE MOLECULAIRE
Transgenic mouse
Genotype phenotype correlation
CRISPRi
Myotonic Dystrophy type 1
Mouse model
PacBio
Fibrosis
Cytoskeleton
CTG repeats
Glucocorticoids
Cell model
Acute coronary syndrome
Myotonic dystrophy
Astrocytes
Heart
Animals
Astrocyte
Oligodendrocyte
Endurance training
Skeletal muscle
RNA splicing
Trinucleotide Repeat Expansion
Glial cells
Maximal force
KNOCKOUT MICE
Expression
Diaphragm
Myotonic Dystrophy
Aging
Oligodendrocytes
Gene editing
Transgenic mouse model
ARN
Therapy
Cell penetrating peptide
Myelin
Dystrophie Myotonique
MBNL
Antisense oligonucleotide
Mouse models
Myotonic dystrophy mouse models
GSK3
Myotonic Dystrophy Type 1
CRISPR/Cas9
Desmin
Knockout
GABA
AAV
Cell culture model
Exercise
Dystrophie myotonique
RNA biology
Myostatin
Humans
Duchenne muscular dystrophy
Thérapie génique
PCR
ACETYLCHOLINESTERASE
Trinucleotide repeat expansion
Dynamin 2
Muscular dystrophy
Acetylcholinesterase knockout mouse
Glucocorticoid-receptor
Brain dysfunction
CMS
Antisense oligonucleotides
Mice
DMSXL mice
CTG repeat instability